Regulation of Vα14 NKT cell-mediated cytotoxicity by a glycolipid ligand/CD1d complex on target cells

被引:0
|
作者
Harada, M
Kamada, N
Kronenberg, M
Nakayama, T
Taniguchi, M
机构
[1] Chiba Univ, Chuou Ku, Chiba 2608670, Japan
[2] CREST Project, Chuou Ku, Chiba 2608670, Japan
[3] La Jolla Inst Allergy & Immunol, La Jolla, CA USA
来源
FASEB JOURNAL | 2001年 / 15卷 / 05期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A1025 / A1025
页数:1
相关论文
共 50 条
  • [1] The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex
    Sidobre, S
    Naidenko, OV
    Sim, BC
    Gascoigne, NRJ
    Garcia, KC
    Kronenberg, M
    JOURNAL OF IMMUNOLOGY, 2002, 169 (03): : 1340 - 1348
  • [2] Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14NKT cells
    Kamada, N
    Iijima, H
    Kimura, K
    Harada, M
    Shimizu, E
    Motohashi, S
    Kawano, T
    Shinkai, H
    Nakayama, T
    Sakai, T
    Brossay, L
    Kronenberg, M
    Taniguchi, M
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (07) : 853 - 861
  • [3] Glycolipid antigen-presentation by CD1d and mechanism of NKT cell activation
    Zajonc, Dirk
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [4] Expression of human CD1d molecules protects target cells from NK cell-mediated cytolysis
    Campos-Martín, Y
    del Moral, MG
    Gozalbo-López, B
    Suela, J
    Martínez-Naves, E
    JOURNAL OF IMMUNOLOGY, 2004, 172 (12): : 7297 - 7305
  • [5] Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells
    Metelitsa, LS
    Naidenko, OV
    Kant, A
    Wu, HW
    Loza, MJ
    Perussia, B
    Kronenberg, M
    Seeger, RC
    JOURNAL OF IMMUNOLOGY, 2001, 167 (06): : 3114 - 3122
  • [6] Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells
    Metelitsa, LS
    Weinberg, KI
    Emanuel, PD
    Seeger, RC
    LEUKEMIA, 2003, 17 (06) : 1068 - 1077
  • [7] Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells
    L S Metelitsa
    K I Weinberg
    P D Emanuel
    R C Seeger
    Leukemia, 2003, 17 : 1068 - 1077
  • [8] Cutting edge:: Influence of the TCR Vβ domain on the avidity of CD1d:α-galactosylceramide binding by invariant Vα14 NKT cells
    Schümann, J
    Voyle, RB
    Wei, BY
    MacDonald, HR
    JOURNAL OF IMMUNOLOGY, 2003, 170 (12): : 5815 - 5819
  • [9] CD1d antigen presentation: treats for NKT cells
    Dale I Godfrey
    James McCluskey
    Jamie Rossjohn
    Nature Immunology, 2005, 6 : 754 - 756
  • [10] CD1d antigen presentation: treats for NKT cells
    Godfrey, DI
    McCluskey, J
    Rossjohn, J
    NATURE IMMUNOLOGY, 2005, 6 (08) : 754 - 756